IP Library Granted Patent US 10,031,129
Granted Patent B2
US 10,031,129 · App. 14/035,257 · Granted Jul 24, 2018

G-protein coupled receptor polypeptides involved in sensory transduction

Inventors: Charles S. Zuker (San Diego, CA); Jon Elliot Adler (Pacific Beach, CA); Juergen Lindemeier (Werl, DE)
Assignee: The Regents of the University of California
G01N33/5041C07K14/705C07K14/723
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,031,129
App. No.
14/035,257
Granted
Jul 24, 2018
Kind
B2
Abstract

The invention provides isolated nucleic acid and amino acid sequences of sensory cell specific G-protein coupled receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of sensory cell specific G-protein coupled receptors.

Claims (27)

1. An isolated polypeptide comprising a sensory transduction G-protein coupled receptor, the receptor is selected from the group consisting of:

(i) a receptor comprising greater than about 95% amino acid sequence identity to the amino acid sequence of SEQ ID NO:1, wherein the isolated polypeptide: is not 100% identical to SEQ ID NO:1, specifically binds to a compound that modulates taste, and is expressed by a recombinant cell engineered to express the isolated polypeptide, and wherein said compound that modulates taste specifically binds to a sensory transduction G-protein coupled receptor having the amino acid sequence set forth in SEQ ID NO: 1, and wherein said recombinant cell is further engineered to express a G-protein that functionally couples to the isolated polypeptide; and

(ii) a receptor comprising greater than about 95% amino acid sequence identity to the amino acid sequence of SEQ ID NO:2, wherein the isolated polypeptide: is not 100% identical to SEQ ID NO:2, specifically binds to a compound that modulates taste, and is expressed by a recombinant cell engineered to express the isolated polypeptide, and wherein said compound that modulates taste specifically binds to a sensory transduction G-protein coupled receptor having the amino acid sequence set forth in SEQ ID NO: 2, and wherein said recombinant cell is further engineered to express a G-protein that functionally couples to the isolated polypeptide.

2. The isolated polypeptide of claim 1 , wherein the isolated polypeptide expressed by the recombinant cell is covalently linked to a heterologous polypeptide, forming a chimeric polypeptide.

3. The isolated polypeptide of claim 2 , wherein the heterologous polypeptide is a heterologous GPCR transmembrane domain.

4. The isolated polypeptide of claim 2 , wherein the heterologous polypeptide is a heterologous GPCR extracellular domain.

5. The isolated polypeptide of claim 2 , wherein the heterologous polypeptide is a heterologous GPCR transmembrane domain linked to a heterologous GPCR extracellular domain.

6. The isolated polypeptide of claim 2 , wherein the heterologous polypeptide is green fluorescent protein.

7. The isolated polypeptide of claim 2 , wherein the heterologous polypeptide is J-gal.

8. The isolated polypeptide of claim 2 , wherein the heterologous polypeptide is a glutamate receptor.

9. The isolated polypeptide of claim 2 , wherein the heterologous polypeptide is a rhodopsin presequence.

10. A composition comprising:

(i) the recombinant cell expressing the isolated polypeptide according to claim 1 , and

(ii) at least one synthetic or naturally occurring inhibitor, activator or modulator compound, wherein said compound is to be assayed for binding to the isolated polypeptide.

11. An isolated polypeptide comprising a sensory transduction G-protein coupled receptor covalently linked to a heterologous polypeptide forming a chimeric polypeptide, the receptor is selected from a group consisting of:

(i) an isolated polypeptide comprising greater than about 95% amino acid sequence identity to the amino acid sequence of SEQ ID NO:1, wherein the isolated polypeptide specifically binds to a compound that modulates taste and is expressed by a recombinant cell engineered to express the isolated polypeptide, and wherein said recombinant cell is further engineered to express a G-protein that functionally couples to the isolated polypeptide, wherein said compound that modulates taste specifically binds to a sensory transduction G-protein coupled receptor having the amino acid sequence set forth in SEQ ID NO: 1; and

(ii) an isolated polypeptide comprising greater than about 95% amino acid sequence identity to the amino acid sequence of SEQ ID NO:2, wherein the isolated polypeptide specifically binds to a compound that modulates taste and is expressed by a recombinant cell engineered to express the isolated polypeptide, and wherein said recombinant cell is further engineered to express a G-protein that functionally couples to the isolated polypeptide, and wherein said compound that modulates taste specifically binds to a sensory transduction G-protein coupled receptor having the amino acid sequence set forth in SEQ ID NO: 2.

12. The isolated polypeptide of claim 11 , wherein the heterologous polypeptide is a heterologous GPCR transmembrane domain.

13. The isolated polypeptide of claim 11 , wherein the heterologous polypeptide is a heterologous GPCR extracellular domain.

14. The isolated polypeptide of claim 11 , wherein the heterologous polypeptide is a heterologous GPCR transmembrane domain linked to a heterologous GPCR extracellular domain.

15. The isolated polypeptide of claim 11 , wherein the heterologous polypeptide is green fluorescent protein.

16. The isolated polypeptide of claim 11 , wherein the heterologous polypeptide is J-gal.

17. The isolated polypeptide of claim 11 , wherein the heterologous polypeptide is a glutamate receptor.

18. The isolated polypeptide of claim 11 , wherein the heterologous polypeptide is a rhodopsin presequence.

19. A composition comprising:

(i) the recombinant cell expressing the isolated polypeptide according to claim 11 , and

(ii) at least one synthetic or naturally occurring inhibitor, activator or modulator compound, wherein said compound is to be assayed for binding to the isolated polypeptide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2015
From: ZUKER, CHARLES S.; ADLER, JON ELLIOT; LINDEMEIER, JUERGEN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 034810/0147 →
CONFIRMATORY LICENSE Recorded Nov 19, 2013
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031674/0188 →
Continuity (8)
Continuation 13290026 · Nov 4, 2011
Continuation 12960409 · Dec 3, 2010
Division 11716362 · Mar 8, 2007
Continuation 10096144 · Mar 8, 2002
Continuation 09361631 · Jul 27, 1999
Provisional Application 60095464 · Jul 28, 1998
Provisional Application 60112747 · Dec 17, 1998
Related Publication 20140065643A1 · Mar 6, 2014